LifeMD rises on collaboration for improved access to menopause medication

LifeMD

21/09/2023 15:46

** Shares of telehealth service provider LifeMD  LFMD.O 
rise 2.3% to $4.41, set to snap a 4-day losing streak
    ** Co says it is partnering with Virginia-based private
company Ascend Therapeutics to provide telehealth services to
improve access to EstroGel 0.06%
    ** EstroGel is an FDA approved gel that can help manage some
of the symptoms of menopause
    ** Including session gains, shares have more than doubled
YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))